ATLANTA, GA -- (MARKET WIRE) -- November 16, 2006 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced winning the “Best Partnership Alliance of the Year” award with AstraZeneca at the Annual Scrip Awards Dinner on Wednesday, November 15, 2006 at the Grosvenor House in London, England.
